Internal Server Error

Sprout Pharmaceuticals - About the company

Sprout Pharmaceuticals is an acquired company based in Raleigh (United States), founded in 2011. It operates as a Developer of drugs for hypoactive sexual desire disorder in women. Sprout Pharmaceuticals has raised $185M in funding, with last known valuation of $*****. The company has 31 active competitors, including 11 funded and 6 that have exited. Its top competitors include companies like Gameto, Rejoni and Hope Medicine.

Company Details

Sprout Pharmaceuticals has developed drugs for women's health. The company has developed an FDA-approved non-hormonal pill called ADDYI to cure Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
Phone Number
+1 **********
Registered Address
4350 Lassiter at North Hills Ave #260 Raleigh, NC 27609
Key Metrics
Founded Year
2011
Location
Raleigh, United States
Stage
Acquired
Total Funding
$185M in 10 rounds
Latest Funding Round
Last Known Valuation
$***** as on Sep 04, 2019
Ranked
Employee Count
31 as on Feb 28, 2026
Similar Companies
Exit Details
Acquired by Bausch Health (Aug 20, 2015)

Sprout Pharmaceuticals's acquisition details

Sprout Pharmaceuticals got acquired by Bausch Health on Aug 20, 2015 at an acquisition amount of $1B.
Click here to take a look at Sprout Pharmaceuticals's acquisition in detail
Sign up to download Sprout Pharmaceuticals' company profile

Sprout Pharmaceuticals's funding and investors

Sprout Pharmaceuticals has raised a total funding of $185M over 10 rounds. Its first funding round was on Mar 21, 2012. Sprout Pharmaceuticals has 3 institutional investors.

Here is the list of recent funding rounds of Sprout Pharmaceuticals:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Dec 10, 2024
6582709
Series D
1074155
6550029
3843665
1862962
Apr 14, 2023
6102186
Series D
6692815
8688492
8437253
6573397
Aug 15, 2022
6579862
Series D
4323328
6894066
5698306
9400499
lockAccess funding benchmarks and valuations. Sign up today!

Sprout Pharmaceuticals' founders and board of directors

Founder? Claim Profile

Sprout Pharmaceuticals' employee count trend

Sprout Pharmaceuticals has 31 employees as of Feb 26. Here is Sprout Pharmaceuticals's employee count trend over the years:
Employee count trend for Sprout Pharmaceuticals
lockUncover Sprout Pharmaceuticals' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Sprout Pharmaceuticals's Competitors and alternates

Top competitors of Sprout Pharmaceuticals include Gameto, Rejoni and Hope Medicine. Here is the list of Top 10 competitors of Sprout Pharmaceuticals, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Gameto
Gameto
2020, United States, Series C
Developer of therapeutics for the treatment of fertility and menopause
$127M
58/100
2nd
Logo for Sprout Pharmaceuticals
Sprout Pharmaceuticals
2011, Raleigh (United States), Acquired
Developer of drugs for hypoactive sexual desire disorder in women
$185M
58/100
3rd
Logo for Rejoni
Rejoni
2020, Bedford (United States), Series B
Developer of therapeutics to treat women health conditions
$41.3M
57/100
4th
Logo for Hope Medicine
Hope Medicine
2018, Shanghai (China), Series B
Developer of monoclonal antibodies for the treatment of multiple diseases
$56M
56/100
5th
Logo for Naari
Naari
2007, Noida (India), Acquired
Manufacturer of women care medicines
$19M
51/100
6th
Logo for ObsEva
ObsEva
2012, Geneva (Switzerland), Public
Developer of therapeutics for women's reproductive health and pregnancy
$94.7M
47/100
7th
Logo for Forendo Pharma
Forendo Pharma
2013, Turku (Finland), Acquired
Provider of small molecule based therapeutics for reproductive health
$25.6M
46/100
8th
Logo for PregLem
PregLem
2006, Geneva (Switzerland), Acquired
Drugs for women's reproductive medicine
$57.9M
45/100
9th
Logo for FimmCyte
FimmCyte
2022, Basel (Switzerland), Funding Raised
Developer of therapeutics to treat endometriosis
-
44/100
10th
Logo for Nora Therapeutics
Nora Therapeutics
2007, Palo Alto (United States), Series B
Developer of therapeutics to address IVF failure and recurrent pregnancy loss
$37.8M
43/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Sprout Pharmaceuticals's competitors? Click here to see the top ones

Sprout Pharmaceuticals's Investments and acquisitions

Sprout Pharmaceuticals has made no investments or acquisitions yet.

Reports related to Sprout Pharmaceuticals

Here is the latest report on Sprout Pharmaceuticals's sector:

News related to Sprout Pharmaceuticals

Media has covered Sprout Pharmaceuticals for a total of 3 events in the last 1 year, 1 of them has been about company updates.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Sprout Pharmaceuticals

Explore our recently published companies
  • Wizzme - Bengaluru based, 2025 founded, Unfunded company
  • Astrovirgo.ai - Unfunded company
  • Seed Lab - United Kingdom based, 2026 founded, Unfunded company
  • Kazispace - Kigali based, 2024 founded, Unfunded company
  • Finstock - Hong Kong based, 2023 founded, Unfunded company
  • Capera - Dubai based, 2025 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford